Renowned luminaries in Personalized Medicine
Groundbreaking companies with emerging technologies
More than 1000 peers from around the globe
50 sessions in 3 parallel tracks

CO-HOSTED WITH
STANFORD HEALTH CARE, UCSF, & ORACLE

Why Biobanking?

Biobanks play a crucial role in biomedicine as they maintain a wide array of biospecimens, including blood, saliva, plasma, and purified DNA, linked to phenotypic data and other trait information. Biobanksare changing the face of medical research by making available a wealth of material needed for broad research, to investigate cancerous tissues, allowing access tohealthy controls, and more. This session covers the importance of biobanks for personalized medicine, but also touches uponsome of the primary concerns associated with the management of a biobank. They include meeting standards for sample and data quality and integrity, linking biospecimens with electronic medical records in an integrated healthcare delivery system, and the protection of the individual’s rights and privacy.

FEATURED SPEAKERS

Sir Rory Collins, Frcp, Fmedsci, Chief Executive, Uk Biobank (Oxford)

Rory Collins was appointed Principal Investigator and Chief Executive of UK Biobank in September 2005. In 1985, he became co-director, with Professor Sir Richard Peto, of the University of Oxford's Clinical Trial Service Unit & Epidemiological Studies Unit. Read Full Bio

Joe Vockley, Ph.D., Chief Operating Officer And Chief Scientific Officer, Inova

Dr. Vockley brings 25 years of experience in academic, pharmaceutical, biotechnology CROs and government research to his roles as COO and CSO. His basic research interests are in the fields of cancer and inborn errors of metabolism. Read Full Bio

Catherine Schaefer, Ph.D., Research Scientist II, Division Of Research, Kaiser Permanente

Catherine Schaefer, PhD, has been a research scientist at the Kaiser Permanente Northern California Division of Research since 1989. Dr. Schaefer’s primary research interests include the epidemiology of psychiatric and neurologic disorders, early antecedents of adult chronic disease, and genetic epidemiology. Read Full Bio

 
Web Analytics